CSP-504 - Risperidone Treatment for Military Service Related Chronic Post-Traumatic Stress Disorder.

Trial Profile

CSP-504 - Risperidone Treatment for Military Service Related Chronic Post-Traumatic Stress Disorder.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2016

At a glance

  • Drugs Risperidone (Primary)
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Acronyms CSP-504
  • Most Recent Events

    • 02 Feb 2016 Results of secondary analyses (n = 267) published in the Journal of Clinical Psychiatry
    • 03 Aug 2011 Results published in the JAMA: the Journal of the American Medical Association.
    • 03 Aug 2011 Primary endpoint 'Clinician-Administered-Post-Traumatic-Stress-Disorder-Scale' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top